Additional Capital Requirements. Except as provided in Sections 6, 7 and 8 of this Article, if GENENTECH or ROCHE determines that additional dedicated manufacturing equipment, expansion or adaption of the then existing manufacturing facilities or manufacturing equipment, or construction of an additional manufacturing facility is needed to manufacture a Product to meet Clinical Requirements or Commercial Requirements for the other Party as provided herein, the manufacturing Party shall be solely responsible for the capital costs associated with such project.
Appears in 2 contracts
Sources: Agreement Between Genentech, Inc. And F. Hoffmann La Roche LTD Regarding Commercialization of Genentech's Products Outside the United States (Genentech Inc), Agreement Between Genentech, Inc. And F. Hoffmann La Roche LTD Regarding Commercialization of Genentech's Products Outside the United States (Genentech Inc)